Progression of Myopic Maculopathy: A Systematic Review and Meta-Analysis

Motohiro Itoi1, Osamu Hieda, Natsuki Kusada

  • 1Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Eye & Contact Lens
|October 14, 2022
PubMed
Abstract

Insights

The progression of myopic maculopathy (MM) is linked to its baseline severity. Pathologic myopia (PM) at baseline significantly increases the risk of MM progression, highlighting severity as a key factor.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Myopia Research

Background:

  • Myopic maculopathy (MM) is a leading cause of visual impairment in patients with pathologic myopia (PM) and high myopia (HM).
  • Understanding risk factors for MM progression is crucial for timely intervention and management.
  • Previous studies have explored various risk factors, but a comprehensive analysis based on MM severity is needed.

Approach:

  • A systematic review and meta-analysis of cohort studies published before December 2020 was conducted.
  • Risk factors for MM progression in patients with PM and HM were analyzed.
  • Odds ratios (ORs) for MM progression were calculated across different severity stages using the META-PM classification.

Key Points:

  • Pathologic myopia (PM) at baseline significantly elevates the risk of MM progression (pooled OR: 7.17).
  • Greater baseline myopic maculopathy (MM) severity is strongly associated with increased MM progression.
  • Eyes with MM category 3 or higher showed a substantially increased risk of progression compared to category 2 (pooled OR: 10.95).

Conclusions:

  • The progression of myopic maculopathy (MM) is significantly associated with its baseline severity.
  • Early detection and monitoring of MM severity are critical for predicting and managing disease progression.
  • These findings underscore the importance of the META-PM classification in assessing MM progression risk.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
527
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
698
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
623